CytoSite BioPharma Inc. — Form D
CytoSite BioPharma Inc. of SUDBURY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-09. The offering totals $125K, of which $125K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-09
- Form: D
- Accession: 0001144204-18-026470
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $125K
- Amount sold: $125K
- Investors: 1
- Date of first sale: 2018-05-02
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-311995
Issuer
- Name: CytoSite BioPharma Inc.
- CIK: 0001725090
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 14 PETERSEN CIRCLE, SUDBURY, MA, 01776
- Phone: 978-460-0695
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Richard Smith | Executive Officer | Denver, CO |
| James Jenson | Director | Medford, MA |
| James Jenson | Executive Officer | Medford, MA |
| Robert Gailus | Director | Sudbury, MA |
| Mark Mintun | Director | Sudbury, MA |
| Stephen Sands | Director | Sudbury, MA |
| Michel Chu | Director | Sudbury, MA |
| Ellen Cordo | Executive Officer | Sudbury, MA |
Other filings by this issuer (4)
More